Home / Peptides / Selank
Not FDA-reviewed

Selank

A Russian anxiolytic peptide — Semax’s calmer cousin — with the same evidence caveat

Regulatory status

Selank is used clinically in Russia but has not been reviewed or approved by the FDA or EMA. Most evidence comes from Russian research groups, and large independent trials are lacking. This page is educational, not medical advice.

Class

Anxiolytic peptide

FDA Status

Not reviewed

Typical route

Intranasal

What Selank is

Selank is a synthetic heptapeptide derived from tuftsin, a naturally occurring immune-signaling fragment, with a Pro-Gly-Pro tail added for stability. It was developed at Russia's Institute of Molecular Genetics and is used there — typically as nasal drops — as an anti-anxiety agent. The pitch that draws attention is “anxiolytic effect without the sedation or dependence associated with benzodiazepines.” Outside Russia it has no approved medical use.

The proposed mechanism

Selank is thought to act on the GABA and serotonin systems and to influence the metabolism of enkephalins (the body's own opioid-like peptides), along with effects on BDNF and immune signaling. In plain terms: several plausible pathways have been proposed, but no single mechanism is definitively established, and most of the supporting work is preclinical or from small studies.

What the evidence supports — and what it doesn’t

Reasonably supported

  • Russian clinical use for generalized anxiety, with reports of anxiolytic effect.
  • A tuftsin-derived origin and plausible action on anxiety-related pathways.
  • Generally reported as well-tolerated, without the dependence profile of benzodiazepines.

Not established

  • Large, independent, placebo-controlled Western trials are lacking.
  • The mechanism and effect size in healthy users are not well characterized.
  • Long-term safety and standardized dosing are not defined to FDA standards.
  • Grey-market product identity and purity are unverified.

The honest bottom line

Like Semax, Selank is a real, decades-old drug in Russia with a reasonable biological rationale — not vaporware. But it has not cleared the independent, controlled-trial bar that approval in the US or EU requires, and it is not a substitute for evidence-based treatment of anxiety. Treat it as investigational, and talk to a clinician about options that are proven.

Whatever you take, tracking it honestly beats guessing. Jabbit is a private, ad-free injection and protocol log.

Download on App Store